Trials / Unknown
UnknownNCT03553342
Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Thyroidectomy is a common surgical procedure in France. Recurrent paralysis is one of the main complications. Oral corticosteroid therapy are frequently used at a dosage of 1mg/kg for seven days, in case of recurrent paralysis to obtain remobilization as early as possible. The main objective is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corticoids | Patients will receive corticosteroids therapy: 1mg/kg of prednisolone daily for seven days. |
| OTHER | Placebo | Patients will receive placebo for seven days. |
Timeline
- Start date
- 2018-09-11
- Primary completion
- 2021-09-11
- Completion
- 2022-01-11
- First posted
- 2018-06-12
- Last updated
- 2021-01-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03553342. Inclusion in this directory is not an endorsement.